Piper Sandler & Co’s Allergan plc AGN Stock Holding History

Piper Sandler & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-58,900	Closed	-$9.63M	–	21
2017 Q4	$9.63M	Buy	+58,900	New	+$10.6M	8.36%	5

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Piper Sandler & Co's AGN Position: Q2 2014 in Review

Piper Sandler & Co sold out of Allergan plc (AGN) in Q2 2014, closing a stake of 1,000 shares — an estimated $206K sold.

Piper Sandler & Co first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $206K in Q1 2014. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Piper Sandler & Co reported no remaining Allergan plc position as of Q2 2014 after selling out during the quarter.
Piper Sandler & Co sold 1,000 Allergan plc shares in Q2 2014, an estimated $206K.
Piper Sandler & Co first reported a position in Allergan plc in Q1 2014 and held it in 1 quarter.
Piper Sandler & Co's Allergan plc position peaked at $206K in Q1 2014.
674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Piper Sandler & Co's 13F filing for Q2 2014, filed 14 Aug 2014.